Acknowledgements |
|
13 | (2) |
Prelude |
|
15 | (4) |
Introduction |
|
19 | (10) |
|
SECTION A Focus on the Autistic Spectrum Disorders |
|
|
29 | (76) |
|
What is the purpose of a book like this? |
|
|
31 | (4) |
|
The need for biologically focused interventions |
|
|
35 | (7) |
|
ASD and `inborn errors of metabolism' |
|
|
42 | (2) |
|
Biochemical individuality: The importance of biological differences in clinically heterogenous populations |
|
|
44 | (7) |
|
Is ASD getting more common? |
|
|
51 | (2) |
|
A brief history of research on ASD |
|
|
53 | (3) |
|
Consideration of some strongly held views |
|
|
56 | (9) |
|
Early presenting features and risk factors |
|
|
65 | (7) |
|
|
72 | (29) |
|
Abnormal glutamate metabolism |
|
|
72 | (2) |
|
Abnormal sterol metabolism |
|
|
74 | (2) |
|
Anxiety, overrarousal, self-injury, aggression, sleep and behaviour problems |
|
|
76 | (4) |
|
|
80 | (1) |
|
|
80 | (1) |
|
Connective tissue disorders |
|
|
81 | (1) |
|
`Cupid's bow' upper lip (aka `Mobius mouth') |
|
|
81 | (1) |
|
Enlarged head circumference |
|
|
81 | (1) |
|
Facial asymmetries (hemifacial microsomia) |
|
|
82 | (1) |
|
Gastrointestinal disturbance |
|
|
82 | (3) |
|
General physical overgrowth |
|
|
85 | (1) |
|
|
86 | (2) |
|
Methylmalonic acidaemia, vitamin B12 (methylcobalamin) and cobalt levels |
|
|
88 | (3) |
|
|
91 | (1) |
|
|
91 | (1) |
|
|
92 | (1) |
|
Seizures, fits and epilepsy |
|
|
92 | (5) |
|
Skin pigmentation differences |
|
|
97 | (2) |
|
Thumb adduction, external ear rotation, upper limb malformation and 6th and 7th cranial nerve abnormalities |
|
|
99 | (1) |
|
|
99 | (2) |
|
Genetic conditions seen in the ASDs |
|
|
101 | (4) |
|
SECTION B Genetic Conditions Seen in the Autistic Spectrum Disorders |
|
|
105 | (260) |
|
|
107 | (1) |
|
2 Chromosome 2q37 deletion |
|
|
108 | (1) |
|
|
109 | (2) |
|
|
111 | (2) |
|
|
113 | (1) |
|
|
114 | (1) |
|
7 22q13 deletion syndrome |
|
|
115 | (4) |
|
|
119 | (1) |
|
9 Adenylosuccinate Iyase (ADSL) deficiency |
|
|
119 | (3) |
|
10 Adrenomyeloneuropathy (AMN) |
|
|
122 | (2) |
|
11 Angelman syndrome (AS) |
|
|
124 | (8) |
|
|
132 | (3) |
|
|
135 | (3) |
|
14 Autism secondary to autoimmune lymphoproliferative syndrome (ALPS) |
|
|
138 | (3) |
|
15 Bannayan-Riley-Ruvalcaba syndrome |
|
|
141 | (2) |
|
16 Basal cell naevus syndrome (BCNS) |
|
|
143 | (3) |
|
17 Biedl-Bardet syndrome (BBS) |
|
|
146 | (4) |
|
|
150 | (4) |
|
19 Cortical Dysplasia-Focal Epilepsy (CDFE) syndrome |
|
|
154 | (2) |
|
|
156 | (4) |
|
21 Coffin-Lowry syndrome (CLS) |
|
|
160 | (2) |
|
|
162 | (2) |
|
|
164 | (2) |
|
24 Cole-Hughes macrocephaly syndrome (CHMS) |
|
|
166 | (1) |
|
25 Congenital adrenal hyperplasia (CAH) |
|
|
167 | (3) |
|
|
170 | (2) |
|
27 De Lange syndrome (CdLS) |
|
|
172 | (5) |
|
28 Juvenile dentatorubral-pallidoluysian atrophy (JDPLA) |
|
|
177 | (3) |
|
29a DiGeorge syndrome I (DGS I) |
|
|
180 | (6) |
|
29b DiGeorge syndrome II (DGS II) |
|
|
186 | (1) |
|
30 Dihydropyrimidine dehydrogenase (DPYS) deficiency |
|
|
187 | (3) |
|
|
190 | (12) |
|
|
202 | (3) |
|
33 Duchenne (DMD) and Becker (BMD) muscular dystrophy |
|
|
205 | (8) |
|
34 Ehlers-Danlos syndrome (EDS) |
|
|
213 | (3) |
|
|
216 | (15) |
|
36 Fragile-X permutation (partial methylation defects) |
|
|
231 | (1) |
|
37 GAMT deficiency (guanidinoacetate methyltransferase deficiency) |
|
|
231 | (4) |
|
|
235 | (6) |
|
39 HEADD syndrome (Hypotonia, Epilepsy, Autism and Developmental Delay) |
|
|
241 | (1) |
|
40 L-2-hydroxyglutaric aciduria (L-2 HGAA) |
|
|
242 | (2) |
|
41 Hyper IgE syndrome with autism (HIES) |
|
|
244 | (2) |
|
42 Hypomelanosis of Ito (HI) |
|
|
246 | (2) |
|
|
248 | (2) |
|
|
250 | (8) |
|
|
258 | (1) |
|
|
259 | (2) |
|
47 2-methylbutyryl-CoA dehydrogenase deficiency |
|
|
261 | (1) |
|
|
262 | (4) |
|
|
266 | (1) |
|
50 Myotonic dystrophy type 1 (MD 1) |
|
|
267 | (3) |
|
51 Neurofibromatosis type 1 (NF 1) |
|
|
270 | (8) |
|
|
278 | (2) |
|
|
280 | (1) |
|
54 Ornithine carbamyltransferase deficiency (OCTD) |
|
|
281 | (1) |
|
55 Oculocutaneous albinism (OCA) |
|
|
282 | (2) |
|
56 Orstavik 1997 syndrome |
|
|
284 | (1) |
|
|
285 | (11) |
|
|
296 | (1) |
|
59 Port-wine facial staining and autism |
|
|
297 | (1) |
|
60 Potocki-Lupski syndrome (PTLS) |
|
|
298 | (2) |
|
61 Prader-Willi syndrome (PWS) |
|
|
300 | (4) |
|
|
304 | (1) |
|
|
305 | (6) |
|
63b Rett syndrome (Hanefeld variant) (RSHV) |
|
|
311 | (2) |
|
64 Rubinstein-Taybi syndrome |
|
|
313 | (2) |
|
|
315 | (1) |
|
66 Smith-Lemli-Opitz syndrome (SLOS) |
|
|
316 | (6) |
|
67 Smith-Magenis syndrome (SMS) |
|
|
322 | (4) |
|
|
326 | (2) |
|
69 Succinic semialdehyde dehydrogenase (SSADH) deficiency |
|
|
328 | (4) |
|
|
332 | (2) |
|
|
334 | (5) |
|
72 Trichothiodystrophy (TTD) |
|
|
339 | (3) |
|
73 Tuberous sclerosis complex (TSC) |
|
|
342 | (5) |
|
|
347 | (2) |
|
75 Unilateral cerebellar hypoplasia syndrome |
|
|
349 | (1) |
|
76 Velocardiofacial syndrome (VCFS) |
|
|
350 | (1) |
|
77 Williams syndrome (WS) |
|
|
351 | (9) |
|
78 Hereditary xanthinuria type II |
|
|
360 | (1) |
|
79 Xeroderma pigmentosa (complementation group C) |
|
|
361 | (1) |
|
80 X-linked ichthyosis (XLI) |
|
|
362 | (3) |
|
SECTION C Some Conditions with Similarities to ASD |
|
|
365 | (18) |
|
81 Alpha-thalassaemia/mental retardation syndrome, nondeletion type, X-linked (ATRX) |
|
|
367 | (3) |
|
82 Carbohydrate-deficient glycoconjugate syndrome, Type 1a (CDG1A) |
|
|
370 | (1) |
|
|
370 | (1) |
|
|
371 | (1) |
|
85 Methylenetetrahydrofolate reductase (MTHFR) deficiency (+/- homocystinuria) |
|
|
372 | (4) |
|
86 PEHO syndrome (progressive encephalopathy with oedema, hypsarrythmia and optic atrophy |
|
|
376 | (1) |
|
87 Simpson-Golabi-behmel syndrome type 1 (SGBS1) |
|
|
377 | (2) |
|
|
379 | (1) |
|
|
380 | (3) |
|
SECTION D Some Promising Recent Developments in ASD Research |
|
|
383 | (18) |
|
|
385 | (1) |
|
|
386 | (9) |
|
3 Potential correction of `nonsense' mutations |
|
|
395 | (1) |
|
4 Differences in the gastrin-releasing peptide receptor (GRPR) gene |
|
|
396 | (1) |
|
5 Differences in glutamate mechanisms and metabolism |
|
|
397 | (1) |
|
6 Differences in oxytocin |
|
|
398 | (1) |
|
|
398 | (1) |
|
|
399 | (1) |
|
|
399 | (2) |
|
|
401 | (11) |
|
Appendix A Information and Support |
|
|
403 | (7) |
|
1 Genetic Information and support |
|
|
403 | (1) |
|
2 Sites providing information on particular aspects of ASD |
|
|
404 | (1) |
|
3 Autism research charities |
|
|
405 | (1) |
|
4 Some relevant organizations and charities dealing with and funding research on related conditions |
|
|
405 | (1) |
|
5 Some relevant professional organizations |
|
|
406 | (1) |
|
6 General information on rare biomedical conditions |
|
|
407 | (1) |
|
7 Searching for further information |
|
|
408 | (1) |
|
8 Some clinical and academic journals relevant to neurobiological issues in ASD |
|
|
409 | (1) |
|
Appendix B Further Reading |
|
|
410 | (2) |
References |
|
412 | (114) |
Index |
|
526 | |